ACADIA PHARMACEUTICALS INC. - US0042251084 (Aktie)
London
| Kurs | Diff.% | Datum & Zeit | Bid Volumen | Bid | Ask | Ask Volumen |
|---|---|---|---|---|---|---|
16,29 USD
|
-14,712% | 17.09.2024 15:33 | 500,00 | 18,11 | - | - |
| Kontakt | |
|---|---|
|
|
ACADIA Pharmaceuticals Inc. Sorrento Valley Blvd. 92121, San Diego, CA, US |
| Telefon | +1 (858) 558-2871 |
| Fax | +1 (858) 558-2872 |
| info@acadia-pharm.com | |
| Internet | http://www.acadia-pharm.com |
| IR Kontakt/PR Kontakt | -/- |
| Symbol | |
| Ende des Geschäftsjahres | 31.12.2025 |
| Marktkapitalisierung | 2.978.928.731,68 EUR |
| Anteilseigner |
|---|
| Vorstand | |
|---|---|
| Dr. Stephen Biggar | Chairman of Board of Directors |
| Dr. Edmund Harrigan | Member of Board of Directors |
| Dr. Elizabeth Garofalo | Member of Board of Directors |
| James Daly | Member of Board of Directors |
| Julian Baker | Member of Board of Directors |
| Laura Brege | Member of Board of Directors |
| Dr. Adora Ndu | Member of Board of Directors |
| Daniel Soland | Member of Board of Directors |
| Unternehmensprofil |
|---|
| - |
© 2000 - 2025 UniCredit Bank Austria AG. Bitte beachten Sie die Nutzungsbedingungen
Daten und Kursinformationen von FactSet
Fondsdaten von Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
